{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "6 months",
      "Humoral immunity",
      "Real-world data",
      "SARS-CoV-2",
      "mRNA vaccine"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35568366",
  "DateCompleted": {
    "Year": "2022",
    "Month": "09",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "01",
    "Day": "24"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "05",
        "Day": "11"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ijid.2022.05.026",
      "S1201-9712(22)00289-2"
    ],
    "Journal": {
      "ISSN": "1878-3511",
      "JournalIssue": {
        "Volume": "122",
        "PubDate": {
          "Year": "2022",
          "Month": "Sep"
        }
      },
      "Title": "International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",
      "ISOAbbreviation": "Int J Infect Dis"
    },
    "ArticleTitle": "Long-term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers.",
    "Pagination": {
      "StartPage": "1",
      "EndPage": "7",
      "MedlinePgn": "1-7"
    },
    "Abstract": {
      "AbstractText": [
        "This study aimed to assess kinetics and predictive variables of humoral immune response to mRNA SARS-CoV-2 vaccine administration.",
        "We collected blood samples before (T0) and 15, 90, and 180 days after vaccination (T1, T2, and T3, respectively). The Quant SARS-CoV-2 Immunoglobulin (IgG) II Chemiluminescent Microparticle Immunoassay was used to determine anti-spike IgG.",
        "In almost 3000 healthcare-collected blood samples at the three time points, we found the following: at 15 days postvaccination, 97.6% of subjects presented a robust IgG anti-spike response (>4160 AU/ml); then, at three and six months, it decreased in median 6.5-fold to 35.0% and 3.0-fold to 3.3%, respectively. A linear mixed-effects model supported that female gender, younger age groups, and being seropositive prevaccination maintained higher antibody titers. Curves became tighter with time progression, although titers from seropositive subjects decrease at a slower rate than seronegative ones.",
        "These findings strengthen the case for a steep decrease of anti-SARS-CoV-2 antibodies up to six months, suggesting that serological evaluation might guide the need for periodic booster vaccinations in specific groups prone to lower antibody titers."
      ],
      "CopyrightInformation": "Copyright \u00a9 2022. Published by Elsevier Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Occupational Health, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal. Electronic address: jmrfos@gmail.com."
          }
        ],
        "LastName": "Oliveira-Silva",
        "ForeName": "Joana",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Pathology, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Reis",
        "ForeName": "Teresa",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Pathology, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Lopes",
        "ForeName": "Cristiana",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Occupational Health, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Batista-Silva",
        "ForeName": "Ricardo",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Centro Hospitalar Universit\u00e1rio do Porto, Portugal; i3S Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, Portugal; Hospital de S\u00e3o Martinho, Valongo, Portugal."
          }
        ],
        "LastName": "Ribeiro",
        "ForeName": "Ricardo",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Pathology, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Marques",
        "ForeName": "Gilberto",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Occupational Health, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Pacheco",
        "ForeName": "Vania",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Occupational Health, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Rodrigues",
        "ForeName": "Tiago",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Occupational Health, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Afonso",
        "ForeName": "Alexandre",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Occupational Health, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Pinheiro",
        "ForeName": "V\u00edtor",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Pathology, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Ara\u00fajo",
        "ForeName": "Luc\u00edlia",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Pathology, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Rodrigues",
        "ForeName": "Fernando",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Occupational Health, Centro Hospitalar e Universit\u00e1rio de Coimbra, Praceta Professor Mota Pinto, Coimbra, Portugal."
          }
        ],
        "LastName": "Antunes",
        "ForeName": "Isabel",
        "Initials": "I"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Canada",
    "MedlineTA": "Int J Infect Dis",
    "NlmUniqueID": "9610933",
    "ISSNLinking": "1201-9712"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunoglobulin G"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Messenger"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "diagnosis",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Personnel"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunoglobulin G"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA, Messenger"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}